Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage
- 2 October 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 406 (2), 219-225
- https://doi.org/10.1016/s0014-2999(00)00691-9
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Erythropoietin Prevents Place Navigation Disability and Cortical Infarction in Rats with Permanent Occlusion of the Middle Cerebral ArteryBiochemical and Biophysical Research Communications, 1998
- Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage.Stroke, 1994
- Effects of Intravenous Administration of Recombinant Human Erythropoietin in Rats Subject to Hemorrhagic ShockNephron, 1993
- Relation between angiographic cerebral vasospasm and regional CBF in patients with SAHActa Neurologica Scandinavica, 1990
- Ischemic Flow Threshold for Extracellular Glutamate Increase in Cat CortexJournal of Cerebral Blood Flow & Metabolism, 1989
- Evaluation of the stability of human erythropoietin in samples for radioimmunoassayKlinische Wochenschrift, 1988
- Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.Stroke, 1985
- Cerebral edema following experimental subarachnoid hemorrhage.Stroke, 1982
- Physiological and morphometric analysis of the microcirculation of the cerebral cortex under acute vasospasm.Stroke, 1981
- Morphometry of brain parenchymal vessels following subarachnoid hemorrhage.Stroke, 1980